Ubs Group Ag Olink Holding Ab (Publ) Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Olink Holding Ab (Publ) stock. As of the latest transaction made, Ubs Group Ag holds 87,516 shares of OLK stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,516

Previous 253,400 65.46%

Holding current value

$2.25 Million

Previous $6.37 Million 67.72%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$21.81 - $25.14 $3.62 Million - $4.17 Million	-165,884 Reduced 65.46%	87,516 $2.06 Million
Q4 2023 Feb 09, 2024	BUY	$14.29 - $25.95 $3.56 Million - $6.46 Million	248,900 Added 5531.11%	253,400 $6.37 Million
Q3 2023 Nov 09, 2023	SELL	$14.45 - $20.34 $18,785 - $26,442	-1,300 Reduced 22.41%	4,500 $66,000
Q2 2023 Aug 11, 2023	SELL	$17.13 - $23.74 $22,731 - $31,502	-1,327 Reduced 18.62%	5,800 $108,000
Q1 2023 May 12, 2023	BUY	$19.34 - $24.11 $26,727 - $33,320	1,382 Added 24.06%	7,127 $160,000

Q4 2022 Feb 08, 2023	BUY	$12.64 - $25.52 $568 - $1,148	45 Added 0.79%	5,745 $145,000
Q3 2022 Nov 10, 2022	BUY	$12.14 - $18.42 $24,802 - $37,632	2,043 Added 55.87%	5,700 $69,000
Q2 2022 Aug 10, 2022	SELL	$8.95 - $19.24 $30,555 - $65,685	-3,414 Reduced 48.28%	3,657 $56,000
Q1 2022 May 16, 2022	BUY	$11.33 - $19.3 $50,905 - $86,714	4,493 Added 174.28%	7,071 $125,000
Q4 2021 Feb 14, 2022	BUY	$18.0 - $34.82 $35,352 - $68,386	1,964 Added 319.87%	2,578 $47,000
Q3 2021 Nov 15, 2021	BUY	$23.42 - $37.93 $14,379 - $23,289	614 New	614 $15,000

Others Institutions Holding OLK

# of Institutions

Shares Held

38.1M

Call Options Held

52.2K

Put Options Held

134K

View Full List

About Olink Holding AB (publ)

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Market Cap $3.07B
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

More about OLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account